Skip to Content

W P97 (Primaquine phosphate 26.3 mg (15 mg base))

Pill imprint W P97 has been identified as Primaquine phosphate 26.3 mg (15 mg base).

Primaquine is used in the treatment of malaria prevention; malaria; pneumocystis pneumonia and belongs to the drug class antimalarial quinolines. FDA has not classified the drug for risk during pregnancy. Primaquine 26.3 mg (15 mg base) is not a controlled substance under the Controlled Substance Act (CSA).

Primaquine phosphate 26.3 mg (15 mg base) W P97
Discount Card Promo
Primaquine phosphate
Imprint:
W P97
Strength:
26.3 mg (15 mg base)
Color:
Pink
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimalarial quinolines
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Manufacturer:
Sanofi-Aventis
National Drug Code (NDC):
00024-1596
Inactive Ingredients:
carnauba wax
lactose
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
polysorbate 80
ferric oxide red
magnesium silicate
titanium dioxide
hypromellose 2910 (15000 mPa.s)
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
43063-0225 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide